Murtaza Jafari | Medical and Clinical Biochemistry and Pharmaceutics | Best Researcher Award

Posted on by Innovator Awards

Dr. Murtaza Jafari | Medical and Clinical Biochemistry and Pharmaceutics | Best Researcher Award

Cheragh University of Medical Sciences | Afghanistan

Murtaza Jafari is an Afghan scholar and Assistant Professor recognized for his contributions to biochemistry, genetics, and pharmaceutical sciences. He serves as a lecturer at leading higher-education institutions in Kabul, including Cheragh Medical Institute of Higher Education, Ghalib University, and the Farabi Institute of Medical Sciences, where he teaches biochemistry, biology, genetics, and pharmacy-related subjects while actively participating in research projects. He holds a Doctor of Pharmacy degree from Kabul University and a Master of Science from Persian Gulf University, specializing in biochemical research and nanotechnology-based applications. His academic work includes the synthesis and application of cobalt ferrite magnetic nanoparticles coated with PEG and PEI, focusing on their use in purifying free and genomic DNA, as well as advancing magnetic nanoparticle-assisted DNA extraction methods. With expertise in computational biology tools such as PyMol, AutoDock Vina, AutoDock Tools, and Avogadro, along with strong command of SPSS, Microsoft Office, and modern digital platforms, he contributes to multidisciplinary research across pharmacy and biomedical sciences. His scientific output includes h-index: [provide], total documents: [provide], and citation count: [provide], reflecting his growing influence and academic impact. Fluent in Persian and proficient in English, he is dedicated to fostering scientific development and educational excellence in Afghanistan.

Profile: Google Scholar 

Featured Publications 

Jafari, M. (2022). Microbiological quality (yeast and mold) of dried fruits in Kabul, Afghanistan: A laboratory study. Global Scientific Review, 1, 19–28.

Jafari, M., Shahryar, S., Mohebbi, S., Ahmadi, A., Nazari, R., Haidari, A. R., … (2025). DNA nanostructures as promising anticancer agents: A narrative review. Cancer Treatment and Research Communications, 101029.

Amiri, S. H., Danish, S. M., Azimi, A. W., & Jafari, M. (2024). Gastric cancer incidence among patients referred to Jamhuriat Hospital, Kabul, Afghanistan: A cross-sectional study, 2023. American Journal of Pedagogical and Educational Research, 23.

Tawakuli, Y., Nazari, R., Rasoli, M. R., Jafari, M., & Sultani, F. (2022). Evaluation of narcotics prescribed in surgery: A descriptive study in Kabul, Afghanistan, 2022. Texas Journal of Medical Science, 10, 76–80.

Tawakuli, Y., Jafari, M., Taib, A., & Amiri, S. H. (2022). Evaluation of the risk factors of COVID-19 mortality in health centers of Kabul, Afghanistan: A descriptive cross-sectional study. American Journal of Technology and Applied Sciences, 3, 35–40.

Huanghe Yu | Pharmacology | Best Researcher Award

Posted on by Innovator Awards

Dr. Huanghe Yu | Pharmacology | Best Researcher Award

Hunan University of Chinese Medicine | China

Huanghe Yu is a dedicated researcher whose work centers on uncovering the pharmacodynamics and therapeutic mechanisms of bioactive constituents from traditional Chinese medicine and ethnomedicine for managing rheumatoid arthritis, complemented by the innovation of biomimetic membrane-coated nano-targeted drug delivery systems for natural therapeutics. Recognized through multiple prestigious talent honors at regional and institutional levels, he also holds distinguished accolades for outstanding doctoral scholarship. His academic output reflects substantial influence, with more than thirty SCI-indexed publications, including a significant share as lead or corresponding author, several appearing in journals with impact factors above ten, along with multiple CSCD-core papers. His citation profile demonstrates strong visibility, with a citation count in the high hundreds and an h-index in the mid-teens, supported by a solid body of documents indexed across major databases. He has secured a diverse portfolio of competitive research funding spanning national, provincial, and institutional programs, demonstrating both leadership and continuity in advancing interdisciplinary work. Trained in clinical Chinese medicine with a focus on activity screening of traditional remedies and the development of advanced nano-delivery platforms for rheumatoid arthritis, he continues to integrate ethnopharmacology, nanotechnology, and translational medicine to shape innovative therapeutic strategies.

Profile: Scopus 

Featured Publications 


Author, A., Author, B., Author, C., et al. (2025). Treatment of rheumatoid arthritis by Rhododendron molle G. Don: The anti-inflammatory mechanism of its extract was elucidated by network analysis combined with experimental verification. BMC Complementary Medicine and Therapies.


Author, A., Author, B., Author, C., et al. (2025). Total saponins of Panax japonicus alleviate adjuvant-induced arthritis in rats by regulating macrophage polarization and intestinal microbiota. Journal of Ginseng Research.


Author, A., Author, B., Author, C., et al. (2025). Integrated network pharmacology and metabolomics to explore the mechanism of Kadsura coccinea root in alleviating acetaminophen-induced liver injury. Journal of Ethnopharmacology.


Author, A., Author, B., Author, C., et al. (2025). KadsuraChem: A machine learning-powered LC–MS database for Kadsura phytochemicals and its role in compound identification of Kadsura heteroclita. Journal of Agricultural and Food Chemistry.


Author, A., Author, B., Author, C., et al. (2025). Multifunctional Prussian blue nanoparticles loading with Xuetongsu for efficient rheumatoid arthritis therapy through targeting inflammatory macrophages and osteoclasts. Asian Journal of Pharmaceutical Sciences, 5